---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-004646"
form_type: "8-K"
ticker: "BRKR"
cik: "0001109354"
company_name: "BRUKER CORP"
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T02:45:15.459520+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "medium"
source: SEC EDGAR
---

# Bruker sees Q4 2024 revenue of $970M-$980M; 2025 outlook of upper mid-single digit growth

## Summary
- Preliminary Q4 2024 revenue guidance of $970M to $980M (unaudited, subject to change).
- BSI segment bookings described as solid in the fourth quarter.
- 2025 constant exchange rate revenue growth outlook: upper mid-single digits, assuming low-single digit market growth.
- Company presented at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025.
- Final Q4 and full-year 2024 financial statements have not yet been completed or audited.

## SEC filing metadata
- accession: 0000950170-25-004646
- form_type: 8-K
- ticker: BRKR
- cik: 0001109354
- company_name: BRUKER CORP
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: medium
- sec_items: 2.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1109354/000095017025004646/0000950170-25-004646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1109354/000095017025004646/brkr-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-004646
- JSON: https://secwatch.observer/filing/0000950170-25-004646.json
- Plain text: https://secwatch.observer/filing/0000950170-25-004646.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.